98%
921
2 minutes
20
Phage therapy has been explored and used compassionately in the post-antibiotic era, though phage resistance might pose a serious challenge. The advent of hypervirulent and hypermucoviscous traits in Klebsiella pneumoniae limits therapeutic choices. This study investigated the phage resistance in hypermucoviscous hypervirulent Klebsiella pneumoniae clinical strain Kleb_53. A Klebsiella phage Disc against the Kleb_53 strain was isolated from sewage. The phage exhibited stability between - 20 °C and 60 °C and within the pH range of 3 to 11. The phage adsorption time was 15 min, with a latent period of 30 min and a burst size of 354 virions. The phage-resistant Kleb_53 variants were screened and examined for their phenotypic variations, antibiotic susceptibility, and biofilm formation. Colony morphotype variants were observed, including smooth, rough, and small colony variants. String, aggregation, and wetness tests confirmed reduced mucoviscosity. The plaque morphology differed between the wild and variants. Additionally, resistance to meropenem and third-generation cephalosporins was reversed, whereas the biofilm-forming ability varied among the recovered variants. This study demonstrates that ongoing phage-host interactions drive phenotypic changes and the emergence of phage-resistant variants with altered antibiotic susceptibility and biofilm-forming capacity. It also underscores the need for further research on phage resistance and strategies to overcome it for the effective application of phage therapy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12372256 | PMC |
http://dx.doi.org/10.1186/s12866-025-04268-x | DOI Listing |
Microb Pathog
September 2025
Central Research Laboratory and Molecular Diagnostics, School of Allied Health Sciences, Datta Meghe Institute of Higher Education and Research, Sawangi (Meghe), Postal code 442001, Wardha, Maharashtra, India.
Concerningly, multidrug-resistant bacteria have emerged as a prime worldwide trouble, obstructing the treatment of infectious diseases and causing doubts about the therapeutic accidentalness of presently existing drugs. Novel antimicrobial interventions deserve development as conventional antibiotics are incapable of keeping pace with bacteria evolution. Various promising approaches to combat MDR infections are discussed in this review.
View Article and Find Full Text PDFMicrob Pathog
September 2025
College of Life Sciences and Technology, Beijing University of Chemical Technology, Beijing, 100029, China; Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, China. Electronic address:
The antibiotic-resistant Enterococcus faecium (E. faecium) is a significant health issue requiring alternative therapies. Phages could be an alternative to antibiotics and have promising activity in both in vitro and in vivo experiments.
View Article and Find Full Text PDFMicrobiol Spectr
September 2025
VUB-VIB Center for Structural Biology, Vlaams Instituut voor Biotechnologie and Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, Belgium.
Temperate bacteriophages play a pivotal role in the biology of their bacterial host. Of particular interest are bacteriophages infecting enterohemorrhagic (EHEC) due to their significant contribution to the pathogenicity of its host, most notably by encoding the key virulence factor of this pathogen, the Shiga toxin. To better understand the role of EHEC phages on the functionality of its host, we isolated eight temperate phages from clinical EHEC isolates and characterized their genomic composition, morphology, and receptor targeting.
View Article and Find Full Text PDFFront Cell Infect Microbiol
August 2025
Institute of Microbiology, Braunschweig University of Technology, Braunschweig, Germany.
[This corrects the article DOI: 10.3389/fcimb.2025.
View Article and Find Full Text PDFJ Control Release
September 2025
State Key Laboratory of Bioreactor Engineering, Newworld Institute of Biotechnology, East China University of Science and Technology, Shanghai 200237, PR China. Electronic address:
Live bacterial therapeutics (LBT) represent a transformative modality for managing refractory chronic diseases. However, the absence of optimized microbial chassis systems is a significant barrier to clinical translation. To bridge this gap, we engineered Escherichia coli Nissle 1917 (EcN) into a versatile platform that meets the requirements for strain development and clinical application.
View Article and Find Full Text PDF